ReviewPharmacological research2022
Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment.
Kok-Hou Lok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it